Lange, Christoph G; Xu, Zhan; Patterson, Bruce K et al. (2004) Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS 18:605-13
|
Lieberman, Judy (2004) Tracking the killers: how should we measure CD8 T cells in HIV infection? AIDS 18:1489-93
|
Song, Erwei; Lee, Sang-Kyung; Wang, Jie et al. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347-51
|
Zhang, Dong; Shankar, Premlata; Xu, Zhan et al. (2003) Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 101:226-35
|
Lieberman, Judy; Manjunath, N; Shankar, Premlata (2002) Avoiding the kiss of death: how HIV and other chronic viruses survive. Curr Opin Immunol 14:478-86
|
Lieberman, J; Shankar, P; Manjunath, N et al. (2001) Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98:1667-77
|
Manjunath, N; Shankar, P; Wan, J et al. (2001) Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest 108:871-8
|
Chen, G; Shankar, P; Lange, C et al. (2001) CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98:156-64
|
Trimble, L A; Kam, L W; Friedman, R S et al. (2000) CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood 96:1021-9
|
Trimble, L A; Shankar, P; Patterson, M et al. (2000) Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol 74:7320-30
|
Showing the most recent 10 out of 13 publications